Navigation Links
Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
Date:3/13/2008

- Company Advancing Lead Candidate HspE7 into Phase 2 Clinical Trial in

2008 -

SAN DIEGO, March 13 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation announced today financial results for the year ended December 31, 2007, and highlighted the corporate milestones achieved during the period.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080303/LAM023LOGO)

During 2007, the Company achieved the following corporate milestones:

Progress on Lead Candidate HspE7:

-- Made significant progress on the Company's Phase 1 cervical dysplasia

clinical trial examining the safety of new HspE7 leading to the recent

completion of enrollment and initial dosing of the last cohort in this

trial

-- Presented preclinical data at International Papillomavirus conference

demonstrating that co-administering HspE7 with certain adjuvants

promotes more potent responses than HspE7 alone

-- Demonstrated ability to elicit long-lasting tumor protection in vivo

suggesting that HspE7 may have utility in HPV-related diseases

-- Announced data from NCI-sponsored trial in cervical dysplasia showing

78 percent of patients achieved complete response or reduction of

lesion size by more than 50 percent

Corporate and Financial Achievements:

-- Strengthened the Management team with the addition of Richard Lai Fatt,

Ph.D., as Vice President of Corporate Development, and David Duncan,

Jr., as Vice President of Finance

-- Appointed Sandford D. Smith, President of the International Group and

Executive Vice President of Genzyme Corporation, to the Board of

Directors

-- Assembled a distinguished group of international experts for the

Company's Clinical and Scientific Advisory Board

'/>"/>
SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial
2. Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results
3. Nventa updates progress of cervical dysplasia trial with new HspE7
4. Nventas CEO to present at two upcoming investor conferences
5. Nventa announces publication of HspE7 data
6. Nventa Initiates HspE7 Phase 1 Cervical Dysplasia Trial
7. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
8. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... On September 11, Pharma IQ conducted an interview ... a session that he will lead on “Stem Cells” at ... 17-18, 2015 in London. In the interview posted ... to respond to several questions on the current state of ... cell toxicity, and future trends in the use of stem ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Whitehouse ... been chosen by the Parenteral Drug Association (PDA) ... and 19, 2014) on container closure integrity testing. This ... integrity test methods and philosophies detailed in the recently ... Evaluation. The course will span container closure ...
(Date:9/30/2014)... and Pittsburgh PA (PRWEB) September 30, 2014 ... Research Nurses ( IACRN), a non-profit organization ... for Clinical Research Excellence and Safety (ACRES), ... signing of a strategic alliance agreement, setting the ... vision is to enhance clinical research quality and ...
(Date:9/29/2014)... forefront of diagnostics today, with imaging techniques like ... and NMR (nuclear magnetic resonance) increasing steeply over ... image resolution and quality still limit these techniques ... solution is hyperpolarization, which involves injecting the patient ... following the distribution and fate of specific molecules ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 2Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 4Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 2Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 3Whitehouse Laboratories to Partner with PDA for Educational Course on Container Closure Integrity Testing 4IACRN and ACRES to Support Clinical Research Nurses 2IACRN and ACRES to Support Clinical Research Nurses 3A safer approach for diagnostic medical imaging 2A safer approach for diagnostic medical imaging 3
... 2011 SironRX Therapeutics, a biotechnology company developing ... healing, announced today a $3.4 million Series A ... investors include Cleveland Clinic, JumpStart Inc., Fletcher Spaght ... Early Stage Partners, X Gen Ltd. and a ...
... 2011 Delcath Systems, Inc. (NASDAQ: DCTH ... at the Interventional Radiology and Endovascular Surgery Society Meeting ... – A New Evidenced-Based Technology for the Treatment of ... and featured a presentation by Delcath,s Executive Vice President ...
... Fukushima, it is now imperative to redefine what makes a ... nuclear waste management is not thought out from the beginning, ... an energy choice, according to research that appears today in ... SAGE. According to Allison Macfarlane, associate professor of environmental ...
Cached Biology Technology:SironRX Therapeutics Raises $3.4 Million Series A 2Delcath Systems, Inc. Hosts Symposium on Chemosaturation at the SOBRICE Annual Meeting in Brazil 2Delcath Systems, Inc. Hosts Symposium on Chemosaturation at the SOBRICE Annual Meeting in Brazil 3Nuclear waste requires cradle-to-grave strategy 2Nuclear waste requires cradle-to-grave strategy 3
(Date:9/29/2014)... to a new Food and Brand Lab pilot study, ... participation in the National School Lunch Program (NSLP) by ... 16%! , Chefs Move to Schools (CMTS), an initiative ... schools in order to provide nutrition instruction to students ... , A CMTS event was held in an Upstate ...
(Date:9/29/2014)... team says recently identified radiation detection properties of a ... for homeland security and medical advances. , In a ... of Optics Letters , UT Arlington Physics Professor ... to fabricate transparent nanoscintillators by heating nanoparticles composed of ... formed. A scintillator refers to a material that ...
(Date:9/29/2014)... a bad rap, and understandably so. The grain-of-rice-sized insects ... millions of acres in the Western U.S. and Canada ... popular belief, these pests may not be to blame ... swept through the region. Instead, weather and topography play ... than these bark-boring beetles. , New research led by ...
Breaking Biology News(10 mins):Chefs move to schools can increase school meal participation and vegetable intake among students 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 3Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 2Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 3Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 4
... PITTSBURGHPine trees are one of the biggest contributors to ... airborne chemicals many of which are produced by ... the air. New research from a team led by ... particles formed from pine tree emissions are much more ...
... 2012 Listed below are the selected highlights for the August ... . The August issue is available online at www.genetics.org/content/current ... Copyright 2012. Please feel free to forward to colleagues ... New negative feedback regulators of Egfr signaling in ...
... control the generation and maintenance of biological diversity on ... biology. For land-dwelling organisms such as insects and the ... are one of the main drivers of the evolutionary ... picture is much murkier for ocean dwellers, mainly because ...
Cached Biology News:Carnegie Mellon study shows skin-aging radicals age naturally formed particles in the air 2Carnegie Mellon study shows skin-aging radicals age naturally formed particles in the air 3Genetics Society of America’s GENETICS journal highlights for August 2012 2Genetics Society of America’s GENETICS journal highlights for August 2012 3Genetics Society of America’s GENETICS journal highlights for August 2012 4Drivers of marine biodiversity: Tiny, freeloading clams find the key to evolutionary success 2Drivers of marine biodiversity: Tiny, freeloading clams find the key to evolutionary success 3
This pump accomodates StemSep ; pump feed columns of the following sizes : 0.3in., 0.5in., 0.6in., and 1.0in.....
... assay kit provides complete components including positive ... of DNA fragmentation in cultured cells and ... labeling of apoptotic cells. Internucleosomal ... in mammalian cells. MBLs ApoDIRECT In Situ ...
... SDS and Non-ionic Detergent Removal ... detergent , Very selective, virtually no cross-reactivity ... centrifuge and discard pellet , Economical ... chromatography , Detergents can often interfere with ...
Extracti-Gel D Detergent Removing Gel...
Biology Products: